Reports for Commave Therapeutics SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Commave Therapeutics SA
- Commave Therapeutics SA is currently active and the industry «Operation of investment companies». The legal headquarters are in Genève.
- The management of the company Commave Therapeutics SA consists of 5 persons. The foundation of the company took place on 19.12.2017.
- The last commercial register change was made on 04.06.2025. All changes can be viewed under the section «Notifications» and saved as a PDF.
- The company Commave Therapeutics SA is registered under the UID CHE-377.777.355.
- Auregen BioTherapeutics SA, B-FLEXION Advisors (Switzerland) SA, B-FLEXION Group Holdings SA are registered at the same address.
Management (5)
newest board members
Alessandro Berti,
Peter Agnes,
Nicolas Schnyder,
Frédéric Yves Boder
newest authorized signatories
Alessandro Berti,
Peter Agnes,
Nicolas Schnyder,
Grégory Deballe,
Frédéric Yves Boder
Commercial register information
Entry in the commercial register
19.12.2017
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.3.815.017-0
UID/VAT
CHE-377.777.355
Sector
Operation of investment companies
Purpose (Original language)
Prise de participations dans des sociétés suisses ou étrangères, acquisition, vente, détention et gestion de titres de participations, de licences, de brevets ou de tout autre droit, et de produits pharmaceutiques (y compris de produits à développer), à l'exclusion de toute opération prohibée par la LFAIE (cf. statuts pour but complet).
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young SA | Lancy | 22.03.2021 | ||
Other company names
Past and translated company names
- BOSTON PHARMACEUTICALS HOLDINGS SA
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Commave Therapeutics SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006348239, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 16.08.2024, p. 0/1006108690). De Luca Giampiero n'est plus administrateur;
ses pouvoirs sont radiés. Berti Alessandro, de et à Satigny, est membre du conseil d'administration avec signature collective à deux.
Publication number: HR02-1006108690, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 22.05.2024, p. 0/1006037375). Meister Stefan n'est plus administrateur;
ses pouvoirs sont radiés. L'administrateur Agnes Peter, nommé président, continue à signer collectivement à deux.
Publication number: HR02-1006037375, Commercial Registry Office Geneva, (660)
Commave Therapeutics SA, à Genève, CHE-377.777.355 (FOSC du 23.04.2024, p. 0/1006016029). Agnes Peter, des USA, à Weston, USA, est membre du conseil d'administration avec signature collective à deux.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.